Researchers from Fourth Military Medical University Discuss Research in Monoclonal Antibodies (Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model)

MLA

“Researchers from Fourth Military Medical University Discuss Research in Monoclonal Antibodies (Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model).” Immunotherapy Weekly, 14 Apr. 2021, p. 6154. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.658079720&authtype=sso&custid=ns315887.

APA

Researchers from Fourth Military Medical University Discuss Research in Monoclonal Antibodies (Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model). (2021, April 14). Immunotherapy Weekly, 6154.

Chicago

Immunotherapy Weekly. 2021. “Researchers from Fourth Military Medical University Discuss Research in Monoclonal Antibodies (Inhibition of LDH-A by Oxamate Enhances the Efficacy of Anti-PD-1 Treatment in an NSCLC Humanized Mouse Model),” April 14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.658079720&authtype=sso&custid=ns315887.